Price movement over the last 24 hours
Align Technology, Inc. vs Materials Select Sector SPDR Fund — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Materials Select Sector SPDR Fund trades at $50.83. Which is the better fit depends on your goals.
| ALGN | XLB | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | — |
52-Week High | $207.19 | $53.62 |
52-Week Low | $124.88 | $42.23 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
XLB, the State Street Materials Select Sector SPDR ETF, trades at $50.89 with a 1.21% daily gain. Technical indicators signal a bearish trend with moving averages showing sell pressure, while oscillators remain neutral. Recent news highlights materials sector capital inflows and geopolitical impacts on supply chains. The ETF provides diversified exposure to U.S. materials companies, with a dividend scheduled for June 2026.
Outlook remains cautious due to bearish technicals and geopolitical sensitivity. Investment appeal hinges on sector earnings growth potential amid inflation and supply disruptions. Key risks include macroeconomic volatility and concentrated sector exposure, requiring careful risk assessment for equity investors.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →